Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c] phenanthridine derivatives, a new class of antitumor agents

Journal of Medicinal Chemistry

Volumn 48, Issue 8, 2005, Pages 2772-2777

  Kock, Ilka ^a   Heber, Dieter ^a   Weide, Matthias ^a   Wolschendorf, Ulrich ^a   Clement, Bernd ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINO 11 (2 FURYL)BENZO[C]PHENANTHRIDINIUM PERCHLORATE; 6 AMINO 11 (2,3,4 TRIMETHOXYPHENYL)BENZO[C]PHENANTHRIDINIUM PERCHLORATE; 6 AMINO 11 (2,4 DIMETHOXYPHENYL)BENZO[C]PHENANTHRIDINIUM PERCHLORATE; 6 AMINO 11 (3,4 DIMETHOXYPHENYL)BENZO[C]PHENANTHRIDINIUM PERCHLORATE; 6 AMINO 11 (3,4,5 TRIMETHOXYPHENYL)BENZO[C]PHENANTHRIDINIUM PERCHLORATE; 6 AMINO 11,12 DIHYDRO 11 (2 FURYL)BENZO[C]PHENANTHRIDINIUM CHLORIDE; 6 AMINO 11,12 DIHYDRO 11 (2,3,4 TRIMETHOXYPHENYL)BENZO[C]PHENANTHRIDINIUM CHLORIDE; 6 AMINO 11,12 DIHYDRO 11 (3,4 DIMETHOXYPHENYL)BENZO[C]PHENANTHRIDINIUM CHLORIDE; 6 AMINO 11,12 DIHYDRO 11 (3,4,5 TRIMETHOXYPHENYL)BENZO[C]PHENANTHRIDINIUM CHLORIDE; 6 AMINO 11,12 DIHYDRO 11 (4 HYDROXY 3,5 DIMETHOXYPHENYL)BENZO[C]PHENANTHRIDINIUM CHLORIDE; AMINE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DOXORUBICIN; PHENANTHRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; HOLLOW FIBER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION; TECHNIQUE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PHENANTHRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 17444426732     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0490888     Document Type: Article

References (17)

1. Simeon, S.; Rios, J. L.; Villar, A. Pharmacological activities of benzophenanthridine and phenanthrene alkaloids. Pharmazie 1989, 44, 593-597.
2. Phillips, S. D.; Castle, R. N. A review of the chemistry of the antitumor benzo[c]phenanthridine alkaloids nitidine and fagaronine and of the related antitumor alkaloid coralyne. J. Heterocycl. Chem. 1981, 18, 223-232.
3. Zee-Cheng, R. K.-Y.; Cheng, C. C. Preparation and antileukemic activity of some alkoxybenzo[c]phenanthridinium salts and corresponding dihydro derivatives. J. Med. Chem. 1975, 18, 66-71.
4. Janin, Y. L.; Croisy, A.; Riou, J.-F.; Bisagni, E. Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives. J. Med. Chem. 1993, 36, 3686-3692.
5. Janin, Y. L.; Bisagni, E. A formal new access to the benzo[c] phenanthridine alkaloids, synthesis of nitidine and O-methylfagaronine analogues. Tetrahedron 1993, 49, 10305-10316.
6. Clement, B., Weide, M. Phenanthridinderivate und ihre Herstellung, dt. Patentanmeldung. 195 38 088.6-44, PCT/DE 96/ 01958; EP 0873315; US 006030981; 1995.
7. Clement, B., Weide, M., Wolschendorf, U., Kock, I. A two-step synthesis of cytostatically active benzo[c]phenanthridine derivatives. Angew. Chem., Int. Ed. 2005, 44, 635-638.
8. Takahashi, K.; Okamoto, T.; Yamada, K.; Iida, H. A convenient synthesis of substituted stilbenes by condensation of o- or p-tolunitrile with p-substituted benzaldehydes. Synthesis 1977, 58-59.
9. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 1991, 83, 757-766.
10. Boyd, M. R.; Paull, K. D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 1995, 34, 91-109.
11. Weinstein, J. N.; Myers, T. G.; O'Connor, P. M.; Friend, S. H.; Fornace, A. J., Jr.; Kohn, K. W.; Fojo, T.; Bates, S. E.; Rubinstein, L. V.; Anderson, N. L.; Buolamwini, J. K.; van Osdol, W. W.; Monks, A. P.; Scudiero, D. A.; Sausville, E. A.; Zaharevitz, D. W.; Bunow, B.; Viswanadhan, V. N.; Johnson, G. S.; Wittes, R. E.; Paull, K. D. An information-intensive approach to the molecular pharmacology of cancer. Science 1997, 275, 343-349.
12. Data concerning the NCI screening methods in detail are accessible from the NCI via the Internet from following addresses: http://dtp.nci.nih.gov/ branches/btb/ivclsp.html; http:// dtp.nci.nih.gov/branches/btb/hfa.html.
13. Data concerning test results for established antitumor agents are accessible from the NCI via the Internet from the following address: http://dtp.nci.nih.gov/docs/cancer/searches/ standard_mechanism_list.html.
14. Paull, K. D.; Shoemaker, R. H.; Hodes, L.; Monks, A.; Scudiero, D. A.; Rubinstein, L.; Plowman, J.; Boyd, M. R. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst. 1989, 81, 1088-1092.
15. Paull, K. D.; Lin, C. M.; Malspeis, L.; Hamel, E. Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data. Cancer Res. 1992, 52, 3892-3900.
16. Hollingshead, M. G.; Alley, M. C.; Camalier, R. F.; Abbott, B. J.; Mayo, J. G.; Malspeis, L.; Grever, M. R. In vivo cultivation of tumor cells in hollow fibers. Life Sci. 1895, 57, 131-141.
17. Wolff, J.; Knipling, L. Antimicrotubule properties of benzophenanthridine alkaloids. Biochemistry 1993, 32, 13334-13339.